Back
Day Range
$289.32
$299.88
52-Week Range
$273.71
$458.75
Volume
1,244,160
50D / 200D Avg
$331.17
/
$331.99
Prev Close
$290.33
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 11.5 | 0.2 |
| P/B | 1.5 | 3.0 |
| ROE % | 13.3 | 3.6 |
| Net Margin % | 2.8 | 3.8 |
| Rev Growth 5Y % | 9.5 | 9.9 |
| D/E | 0.8 | 0.2 |
Analyst Price Target
Hold
$382.64
+29.2%
Low: $332.00
High: $425.00
Forward P/E
11.45
Forward EPS
$25.86
EPS Growth (est.)
+0.0%
Est. Revenue
192.94B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$46.13
$43.90 – $51.21
|
229.50B | 2 |
| FY2029 |
$41.55
$39.55 – $46.13
|
214.15B | 2 |
| FY2028 |
$34.43
$31.50 – $37.98
|
208.24B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-28 | $3.10 | $3.33 | +7.4% |
| 2025-10-21 | $4.93 | $6.03 | +22.3% |
| 2025-07-17 | $8.91 | $8.84 | -0.8% |
| 2025-04-22 | $11.41 | $11.97 | +4.9% |
| 2025-01-23 | $3.80 | $3.84 | +1.1% |
| 2024-10-17 | $9.66 | $8.37 | -13.4% |
| 2024-07-17 | $10.01 | $10.12 | +1.1% |
| 2024-04-18 | $10.53 | $10.64 | +1.0% |
Dividend History
7 yr streakYield
0.02%
Payout Ratio
0.27%
Growth (3Y)
10.14%
Growth (5Y)
12.47%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 10, 2026 | Mar 25, 2026 | $1.72 | 2.42% |
| Dec 05, 2025 | Dec 19, 2025 | $1.71 | 2.07% |
| Sep 10, 2025 | Sep 25, 2025 | $1.71 | 2.20% |
| Jun 10, 2025 | Jun 25, 2025 | $1.71 | 1.74% |
| Mar 10, 2025 | Mar 25, 2025 | $1.71 | 1.61% |
| Dec 05, 2024 | Dec 20, 2024 | $1.63 | 1.66% |
| Sep 10, 2024 | Sep 25, 2024 | $1.63 | 1.17% |
| Jun 10, 2024 | Jun 25, 2024 | $1.63 | 1.16% |
| Mar 07, 2024 | Mar 22, 2024 | $1.63 | 1.21% |
| Dec 05, 2023 | Dec 21, 2023 | $1.48 | 1.23% |
| Sep 07, 2023 | Sep 22, 2023 | $1.48 | 1.27% |
| Jun 08, 2023 | Jun 23, 2023 | $1.48 | 1.18% |
| Mar 09, 2023 | Mar 24, 2023 | $1.48 | 1.16% |
| Dec 02, 2022 | Dec 21, 2022 | $1.28 | 0.98% |
| Sep 08, 2022 | Sep 23, 2022 | $1.28 | 1.02% |
| Jun 09, 2022 | Jun 24, 2022 | $1.28 | 0.99% |
| Mar 09, 2022 | Mar 25, 2022 | $1.28 | 1.00% |
| Dec 02, 2021 | Dec 21, 2021 | $1.13 | 1.13% |
| Sep 09, 2021 | Sep 24, 2021 | $1.13 | 1.17% |
| Jun 09, 2021 | Jun 25, 2021 | $1.13 | 1.08% |
Key Takeaways
Revenue grew 9.47% annually over 5 years — modest growth
ROE of 13.29% — decent returns on equity
Generating 3.17B in free cash flow
P/E of 11.54 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.15%
Capital efficient — spends only 0.56% of revenue on capex
Growth
Revenue Growth (5Y)
9.47%
Revenue (1Y)12.62%
Earnings (1Y)-5.32%
FCF Growth (3Y)-31.50%
Quality
Return on Equity
13.29%
ROIC7.89%
Net Margin2.84%
Op. Margin4.07%
Safety
Debt / Equity
0.76
Current Ratio1.24
Interest Coverage5.79
Valuation
P/E Ratio
11.54
Forward P/E11.45
P/B Ratio1.49
EV/EBITDA10.98
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.62% | Revenue Growth (3Y) | 7.80% |
| Earnings Growth (1Y) | -5.32% | Earnings Growth (3Y) | -2.75% |
| Revenue Growth (5Y) | 9.47% | Earnings Growth (5Y) | -1.86% |
| Profitability | |||
| Revenue (TTM) | 199.13B | Net Income (TTM) | 5.66B |
| ROE | 13.29% | ROA | 4.66% |
| Gross Margin | 25.56% | Operating Margin | 4.07% |
| Net Margin | 2.84% | Free Cash Flow (TTM) | 3.17B |
| ROIC | 7.89% | FCF Growth (3Y) | -31.50% |
| Safety | |||
| Debt / Equity | 0.76 | Current Ratio | 1.24 |
| Interest Coverage | 5.79 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 0.27% |
| Dividend Growth (3Y) | 10.14% | Dividend Growth (5Y) | 12.47% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 11.54 | Forward P/E | 11.45 |
| P/B Ratio | 1.49 | P/S Ratio | 0.33 |
| PEG Ratio | -5.63 | Forward PEG | N/A |
| EV/EBITDA | 10.98 | Fwd EV/EBITDA | 7.55 |
| Forward P/S | 0.34 | Fwd Earnings Yield | 8.73% |
| FCF Yield | 4.86% | ||
| Market Cap | 65.35B | Enterprise Value | 89.09B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 199.13B | 176.81B | 171.34B | 156.60B | 138.64B |
| Net Income | 5.66B | 5.98B | 5.99B | 5.89B | 6.10B |
| EPS (Diluted) | 25.12 | 25.68 | 25.22 | 24.28 | 24.73 |
| Gross Profit | 50.90B | 49.24B | 47.01B | 39.95B | 35.99B |
| Operating Income | 8.11B | 8.89B | 8.75B | 8.45B | 8.95B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 121.49B | 116.89B | 108.93B | 102.76B | 97.46B |
| Total Liabilities | 77.47B | 75.46B | 69.52B | 66.43B | 61.33B |
| Shareholders' Equity | 43.88B | 41.32B | 39.31B | 36.24B | 36.06B |
| Total Debt | 33.24B | 32.70B | 26.65B | 25.80B | 24.89B |
| Cash & Equivalents | 9.49B | 8.29B | 6.53B | 7.39B | 4.88B |
| Current Assets | 24.73B | 21.34B | 18.99B | 19.13B | 14.57B |
| Current Liabilities | 19.96B | 19.42B | 19.55B | 18.65B | 15.53B |